Archives: Agenda

KEYNOTE PANEL Where is the clinical trial industry headed this year and beyond?

  • Patient centricity in clinical trials: how can burden be reduced in order to make trials easier for patients to
    participate in?
  • Navigating new regulations around clinical trials smoothly and successfully
  • Technological developments into 2025 and beyond: what changes can we expect to see in the next 3-5
    years?
  • The impact of artificial intelligence: how far can we expect to move forward in the next 12 months?

 

PANEL: Navigating Uncertainty: Mitigating the Impact of External Factors on Clinical Trials in Europe

External factors, including geopolitical tensions and global conflicts, can significantly disrupt clinical trials in Europe, affecting timelines, budgets, and patient recruitment. This session will analyze the implications of these external influences on clinical research and discuss strategies that pharma and biotech companies can employ to mitigate risks and maintain trial integrity.

This session will also cover the EFPIA paper which states “60,000 fewer clinical trial places for Europeans, despite global surge in research projects. “For Europe to be competitive, it needs to function as a unified region” says Nathalie Moll.

 

·       Understand the impact of global conflicts and external factors on clinical trials in Europe.

·       Identify specific challenges posed by geopolitical events, regulatory changes, and market dynamics.

·       Explore strategies and best practices for mitigating risks associated with external factors.

·       Discuss the importance of adaptability and contingency planning in clinical trial management.

Interactive Breakfast Speaker-Hosted Roundtable Discussions

With drinks and refreshments, interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run twice and be led by a table moderator and will focus on a different challenge within clinical trials. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Roundtable 1 Navigating the latest release of ICH E6 (R3): How are you carrying out gap assessments of processes and what changes are you making?

Hosted by Christina Sanchez, Director, Clinical Quality Assurance, Neurocrine Biosciences
Roundtable 2 Postproduction handling and administration of biologics drugs 

Hosted by Kevin Zen, Director, Opthea
Roundtable 3 Collaborative solutions between Sponsors and CROs for accurate site budgeting and forecasting

Hosted by Richard Firth, Associate Director, Development Business Operations, Arcturus Therapeutics
Roundtable 4 Emerging startup company trends and challenges
Roundtable 5 Implications of the latest administration on clinical trial progress